Department of Internal Medicine, Waterbury Hospital, Waterbury.
Department of Medicine, Bridgeport Hospital/Yale New Haven Health, Bridgeport.
Eur J Gastroenterol Hepatol. 2024 Aug 1;36(8):1016-1021. doi: 10.1097/MEG.0000000000002792. Epub 2024 May 29.
Hepatic hydrothorax is a challenging complication of end-stage liver disease, and.patients with this complication can receive model for end-stage liver disease (MELD) exception points if they meet specific criteria as defined by United Network for Organ Sharing (UNOS). This research aimed to analyze the effect of receiving MELD exception points for hepatic hydrothorax on posttransplant mortality, using a national transplant database.
Patients >18 years in the UNOS database awaiting liver transplant between 2012 and 2023 were identified based on their petition for MELD exception points. Using a 1: 1 propensity score-matched analysis, 302 patients who received MELD exception points for hepatic hydrothorax were compared with 302 patients who did not receive MELD exception points.Demographic, clinical and laboratory values were compared. The primary outcome was posttransplant mortality. Multivariate logistic regression controlled for potential confounders.
No significant difference was observed in mean age (58.20 vs 57.62 years), mean initial MELD score (16.93 vs 16.54), or mean Child-Pugh score (9.77 vs 9.74) in patients with hepatic hydrothorax receiving MELD exception points versus their matched cohort who did not recieve exception points. The proportion of males was slightly higher among patients who received MELD exception points (57.6% males vs 53.6% males). A majority of patients in both groups had Child-Pugh grade C (>56%). Patients receiving MELD exception points for hepatic hydrothorax had a statistically significant 44% decrease in the odds of posttransplant death compared to those who did not (OR 0.56; 95% CI 0.37-0.88; P = 0.01). Among the combined cohort, each year increase in age resulted in a 3.9% increase in mortality (OR 1.04; 95% CI 1.01-1.07; P = 0.005), and every one-unit increase in serum creatinine resulted in a 40% increase in mortality (OR 1.40; 95% CI 1.03-1.92; P = 0.03).
Receiving MELD exception points for hepatic hydrothorax is associated with a significant reduction in the odds of posttransplant mortality. These findings underscore the importance of MELD exception points for hepatic hydrothorax among patients with decompensated cirrhosis, potentially improving patient prioritization for liver transplantation and influencing clinical decision-making.
肝性胸水是终末期肝病的一种具有挑战性的并发症,如果符合美国器官共享联合网络 (UNOS) 定义的特定标准,此类患者可以获得终末期肝病模型 (MELD) 例外积分。本研究旨在使用国家移植数据库分析因肝性胸水获得 MELD 例外积分对移植后死亡率的影响。
根据 UNOS 数据库中 2012 年至 2023 年期间申请 MELD 例外积分的患者,确定年龄>18 岁的患者。使用 1:1 倾向评分匹配分析,将 302 例因肝性胸水获得 MELD 例外积分的患者与 302 例未获得 MELD 例外积分的患者进行比较。比较两组的人口统计学、临床和实验室数据。主要结局是移植后死亡率。多变量逻辑回归控制潜在混杂因素。
在因肝性胸水获得 MELD 例外积分的患者与未获得 MELD 例外积分的匹配队列中,两组的平均年龄(58.20 岁比 57.62 岁)、平均初始 MELD 评分(16.93 分比 16.54 分)或平均 Child-Pugh 评分(9.77 分比 9.74 分)均无显著差异。获得 MELD 例外积分的患者中男性比例略高(57.6%男性比 53.6%男性)。两组大多数患者均为 Child-Pugh 分级 C(>56%)。与未获得 MELD 例外积分的患者相比,因肝性胸水获得 MELD 例外积分的患者移植后死亡的几率降低了 44%(OR 0.56;95%CI 0.37-0.88;P=0.01)。在合并队列中,年龄每增加 1 岁,死亡率增加 3.9%(OR 1.04;95%CI 1.01-1.07;P=0.005),血清肌酐每增加 1 个单位,死亡率增加 40%(OR 1.40;95%CI 1.03-1.92;P=0.03)。
因肝性胸水获得 MELD 例外积分与移植后死亡率降低显著相关。这些发现强调了 MELD 例外积分对失代偿性肝硬化患者的重要性,可能会改善肝移植患者的优先排序,并影响临床决策。